I think Secretary Azar is onto something when he says we ought to disclose what the cost to the patient would be.
Michael Burgess: “I think Secretary Azar is onto something when he says we ought to disclose what the cost to the patient would be.”
Editor's note · Context
Burgess supports transparency in drug pricing for patients.
Share
More from Michael Burgess
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I am pleased to yield 4 minutes to the gentleman from Missouri (Mr. Alford) for his comments.
I urge all my fellow colleagues to join me in supporting H.R. 766 and ensuring that we continue to prioritize preventive healthcare initiatives for the betterment of all Americans, and I reserve the balance of my time.





